**Core Concept:** Gemcitabine is an anti-cancer (antineoplastic) drug primarily targeting DNA synthesis and replication. It is a pyrimidine nucleoside analogue that competes with natural pyrimidines, inhibiting ribonucleotide reductase and ultimately leading to DNA chain termination and cell death. It is used in the treatment of various cancers due to its effectiveness against rapidly dividing cells.

**Why the Correct Answer is Right:**
Gemcitabine is mainly used in the treatment of pancreatic cancer, specifically for locally advanced or metastatic disease when other treatments have failed. It is also effective in the treatment of non-small cell lung cancer (NSCLC) and breast cancer, particularly in combination with other chemotherapeutic agents. Its use in these cancers is based on its ability to target rapidly dividing cells, which are abundant in these cancer types.

**Why Each Wrong Option is Incorrect:**
A. Gemcitabine is not primarily used in the treatment of prostate cancer. Prostate cancer treatment primarily involves hormone therapy and radiation.
B. Although gemcitabine is used in the treatment of ovarian cancer, its primary use is in pancreatic cancer.
C. Gemcitabine is not the first-line treatment for brain tumors; this role is typically filled by other chemotherapy agents, radiation therapy, or targeted therapy.
D. Gemcitabine is not primarily used for treating leukemia or lymphoma. These cancers are treated by targeted therapy, immunotherapy, or hematopoietic stem cell transplantation, depending on the specific type of leukemia or lymphoma.

**Clinical Pearl:**
Gemcitabine is a versatile chemotherapeutic agent with applications in several cancer types, particularly those with high rates of cell division (e.g., pancreatic, non-small cell lung cancer, and breast cancer). However, its use in these conditions should be balanced against potential side effects and alternative treatment options.

**Correct Answer:** D. Gemcitabine is mainly used in the treatment of pancreatic cancer, non-small cell lung cancer, and breast cancer.